Top Arecoline Secrets
MI-CP151 was a stage 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre examine To judge many intravenous doses of sifalimumab, in adult people with dermatomyositis or polymyositis (NCT00533091). Major demo objectives were being To guage the protection and tolerability of sifalimumab in dermatomyositis or polymyositis ind